Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline - Business Wire

Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline  Business WireGilead bets big on Tubulis with $5B buy  axios.comGilead to Buy Cancer Biotech Tubulis in $5 Billion Deal  Bloomberg.comGilead pays $3.1B for Tubulis to bolster oncology ADC pipeline  Fierce BiotechGilead to buy Germany's Tubulis for up to $5 billion to boost cancer pipeline  Reuters